Jul 21, 2021
Press Releases
ViaCyte Appoints Dr. Jon Wilensky as Head of Surgery
Accomplished surgeon and researcher brings leadership to optimize subcutaneous delivery approaches as the company advances type 1 diabetes islet replacement therapies in the clinic SAN DIEGO, July 21, 2021 – ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it has appointed Jon Wilensky, MD, MBA, FACS, as Head of Surgery. […]